Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain

NeuroImage

Volumn 54, Issue 1, 2011, Pages 113-122

  Wengenack, T M ^a   Reyes, D A ^b   Curran, G L ^a   Borowski, B J ^b   Lin, J ^c   Preboske, G M ^b   Holasek, S S ^a   Gilles, E J ^a   Chamberlain, R ^c   Marjanska, M ^c   Jack, C R ^b   Garwood, M ^c   Poduslo, J F ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Iron; Magnetic resonance imaging; Thioflavine S

Indexed keywords

AMYLOID BETA PROTEIN; IRON;

ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENSITY GRADIENT; DIFFERENTIAL DIAGNOSIS; ELECTRON SPIN RESONANCE; HIPPOCAMPUS; HISTOPATHOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RELIABILITY; THALAMUS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PLAQUE, AMYLOID; THALAMUS;

EID: 77957939522     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.08.033     Document Type: Article

References (42)

1. Benveniste H., Einstein G., Kim K.R., Hulette C., Johnson G.A. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc. Natl Acad. Sci. USA 1999, 96:14079-14084.
2. Braak H., Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol. 1991, 81:261-268.
3. Chamberlain R., Reyes D., Curran G.L., Marjanska M., Wengenack T.M., Poduslo J.F., Garwood M., Jack C.R. Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease. Magn. Reson. Med. 2009, 61:1158-1164.
4. 2*- weighted MR microscopic images. NMR Biomed. 2002, 15:197-203.
5. Dhenain M., El Tannir El Tayara N., Wu T.D., Guegan M., Volk A., Quintana C., Delatour B. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiol. Aging 2009, 30:41-53.
6. Falangola M.F., Lee S.P., Nixon R.A., Duff K., Helpern J.A. Histological co-localization of iron in A-beta plaques of PS/APP transgenic mice. Neurochem. Res. 2005, 30:201-205.
7. Fujita N. Extravascular contribution of blood oxygenation level- dependent signal changes: a numerical analysis based on a vascular network model. Magn. Reson. Med. 2001, 46:723-734.
8. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 1994, 63:793-807.
9. Haidarliu S., Ahissar E. Size gradients of barreloids in the rat thalamus. J. Comp. Neurol. 2001, 429:372-387.
10. Helpern J.A., Lee S.P., Falangola M.F., Dyakin V.V., Bogart A., Ardekani B., Duff K., Branch C., Wisniewski T., de Leon M.J., Wolf O., O'Shea J., Nixon R.A. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn. Reson. Med. 2004, 51:794-798.
11. Hill J.M., Switzer R.C.I.I.I. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984, 11:595-603.
12. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 1998, 4:97-100.
13. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, A-beta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
14. Huang X., Moir R.D., Tanzi R.E., Bush A.I., Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. NY Acad. Sci. 2004, 1012:153-163.
15. Irizarry M.C., Locascio J.J., Hyman B.T. Beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. Am. J. Pathol. 2001, 158:173-177.
16. Jack C.R., Garwood M., Wengenack T.M., Borowski B.J., Curran G.L., Lin J., Adriany G., Grohn O.H.J., Grimm R., Poduslo J.F. In vivo visualization of Alzheimer's amyloid plaques by MRI in transgenic mice without a contrast agent. Magn. Reson. Med. 2004, 52:1263-1271.
17. Jack C.R., Wengenack T.M., Reyes D.A., Garwood M., Curran G.L., Borowski B.J., Lin J., Preboske G.M., Holasek S.S., Adriany G., Poduslo J.F. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J. Neurosci. 2005, 25:10041-10048.
18. Koeppen A.H. The history of iron in the brain. J. Neurol. Sci. 1995, 134 Suppl:1-9.
19. Lee S.-P., Falangola M.F., Nixon R.A., Duff K., Helpern J.A. Visualization of amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn. Reson. Med. 2004, 52:538-544.
20. Leskovjan A.C., Lanzirotti A., Miller L.M. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage 2009, 47:1215-1220.
21. LeVine S.M. Oligodendrocytes and myelin sheaths in normal, quaking, and shiverer brains are enriched in iron. J. Neurosci. 1991, 29:413-419.
22. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 1997, 760:298-303.
23. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron, and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
24. Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 1993, 61:1171-1174.
25. McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., Yu X., Uljon S., Wang R., Mann D., Dickson D., Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 1999, 6:231-244.
26. Miller L.M., Wang Q., Telivala T.P., Smith R.J., Lanzirotti A., Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 2006, 155:30-37.
27. Mitsumori F., Watanabe H., Takaya N., Garwood M. Apparent transverse relaxation rate in human brain varies linearly with tissue iron concentration at 4.7T. Magn. Reson. Med. 2007, 58:1054-1060.
28. Morris C.M., Candy J.M., Oakley A.E., Bloxham C.A., Edwardson J.A. Histochemical distribution of non-haem iron in the human brain. Acta Anat. 1992, 144:235-257.
29. Poduslo J.F., Wengenack T.M., Curran G.L., Wisniewski T., Sigurdsson E.M., Macura S.I., Borowski B.J., Jack C.R. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol. Dis. 2002, 11:315-329.
30. Robb R.A. A software system for interactive and quantitative analysis of biomedical images. 3D Imaging in Medicine 1990, 60:333-361. Springer Verlag, Berlin-Heidelberg. K.H. Hohne, H. Fuchs, S.M. Pizer (Eds.).
31. Sasaki A., Shoji M., Harigaya Y., Kawarabayashi T., Ikeda M., Naito M., Matsubara E., Abe K., Nakazato Y. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch. 2002, 441:358-367.
32. 2 relaxation at different field strengths. J. Neurol. Sci. 1995, 134 Suppl:10-18.
33. Schultz C., Dick E.J., Cox A.B., Hubbard G.B., Braak E., Braak H. Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys. Neurobiol. Aging 2001, 22:677-682.
34. Smith M.A., Perry G. Free radical damage, iron, and Alzheimer's disease. J. Neurol. Sci. 1995, 134 Suppl:92-94.
35. Vanhoutte G., Dewachter I., Borghgraef P., Van Leuven F., Van der Linden A. Non-invasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn. Reson. Med. 2005, 53:607-613.
36. Vymazal J., Brooks R.A., Patronas N., Hajek M., Bulte J.W., Di Chiro G. Magnetic resonance imaging of brain iron in health and disease. J. Neurol. Sci. 1995, 134 Suppl:19-26.
37. Wadghiri Y.Z., Sigurdsson E.M., Sadowski M., Elliott J.I., Li Y., Scholtzova H., Tang C.Y., Aguinaldo G., Pappolla M., Duff K., Wisniewski T., Turnbull D.H. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn. Reson. Med. 2003, 50:293-302.
38. Wadsworth P.F., Jones H.B., Cavanagh J.B. The topography, structure and incidence of mineralized bodies in the basal ganglia of the brain of cynomolgus monkeys (Macaca fascicularis). Lab Anim. 1995, 29:276-281.
39. Wengenack T.M., Whelan S.L., Curran G.L., Duff K.E., Poduslo J.F. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 2000, 101:939-944.
40. Yablonskiy D.A., Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994, 32:749-763.
41. Yanai T., Masegi T., Ueda K., Manabe J., Teranishi M., Takaoka M., Matsunuma N., Fukuda K., Goto N., Fujiwara K. Vascular mineralization in the monkey brain. Vet. Pathol. 1994, 31:546-552.
42. Zhang J., Yarowsky P., Gordon M.N., Di Carlo G., Munireddy S., van Zijl P.C., Mori S. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn. Reson. Med. 2004, 51:452-457.